Corrigendum to 'NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma' [Canc. Lett. 476 (2020) 48–56]

MLA

Shao Hang Cai, et al. “Corrigendum to ‘NRF2/SHH Signaling Cascade Promotes Tumor-Initiating Cell Lineage and Drug Resistance in Hepatocellular Carcinoma’ [Canc. Lett. 476 (2020) 48–56].” Cancer Letters, vol. 499, Feb. 2021, p. 2. EBSCOhost, https://doi.org/10.1016/j.canlet.2020.06.007.

APA

Shao Hang Cai, Etienne Ho Kit Mok, Hua Jian Yu, Carmen Oi Ning Leung, Hoi Wing Leung, Martina Mang Leng Lei, Victor W.S. Ma, Jing Ping Yun, William C. Cho, Terence Kin Wah Lee, Stephanie Ma, Irene Oi-Lin Ng, & Eunice Yuen Ting Lau. (2021). Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56]. Cancer Letters, 499, 2. https://doi.org/10.1016/j.canlet.2020.06.007

Chicago

Shao Hang Cai, Etienne Ho Kit Mok, Hua Jian Yu, Carmen Oi Ning Leung, Hoi Wing Leung, Martina Mang Leng Lei, Victor W.S. Ma, et al. 2021. “Corrigendum to ‘NRF2/SHH Signaling Cascade Promotes Tumor-Initiating Cell Lineage and Drug Resistance in Hepatocellular Carcinoma’ [Canc. Lett. 476 (2020) 48–56].” Cancer Letters 499 (February): 2. doi:10.1016/j.canlet.2020.06.007.